WHO ICTRP trial
The clinical multicentre study for the realitionship of Gestrinone treatment and…
ChiCTR-TRC-12002327 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-TRC-12002327 |
|---|---|
| Public title | The clinical multicentre study for the realitionship of Gestrinone treatment and AUB |
| Scientific title | The clinical multicentre study for the realitionship of Gestrinone treatment and AUB |
| Primary sponsor | Beijing Obstetrics and Gynecology Hospital, Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Post-market |
| Countries | China |
| Conditions | adenomyosis, endometriosis |
| Interventions | 1:Gestrinone, 2.5 mg, twice per week, last for 3 months;2:Gestrinone, 2.5 mg, 3 times a week, last for 1 months; then 2.5 mg, twice per week, last for 2 months;3:Gestrinone, 2.5 mg, 3 times a week, last for 3months. It can accompany use… |
| Registration date | Jun 25, 2012 |
| Target size | 1:54;2:54;3:54 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: